Format

Send to

Choose Destination
Neuropsychobiology. 2006;53(2):83-7. Epub 2006 Feb 23.

Intravenous mirtazapine is safe and effective in the treatment of depressed inpatients.

Author information

1
University Clinic for Psychiatry I, Christian Doppler Clinic, Salzburg, Austria. m.muehlbacher@salk.at

Abstract

Mirtazapine is a third-generation antidepressant with a dual mode of action. The oral administration has been shown to be effective and safe in the treatment of depressed patients. In this multicenter naturalistic study, we assessed the safety, tolerability, and therapeutic efficacy of intravenously administered mirtazapine in 80 moderately to severely depressed inpatients during a treatment period of 14 days. We found a significant decrease of the Hamilton Depression Rating Scale total score compared to baseline. Side effects were mild and transient. Our data indicate that intravenous mirtazapine is an effective, safe and well-tolerated treatment for depressed inpatients.

PMID:
16511339
DOI:
10.1159/000091724
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for S. Karger AG, Basel, Switzerland
Loading ...
Support Center